Wolverine Asset Management LLC Surrozen, Inc. Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$0.42 - $41.25 $420 - $41,250	-1,000 Reduced 11.46%	7,725 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.26 - $46.35 $94 - $16,871	364 Added 4.35%	8,725 $17,000
Q2 2022 Aug 03, 2022	SELL	$2.14 - $3.43 $823 - $1,320	-385 Reduced 4.4%	8,361 $25,000
Q1 2022 May 04, 2022	SELL	$2.2 - $6.01 $937 - $2,560	-426 Reduced 4.64%	8,746 $26,000
Q4 2021 Feb 09, 2022	BUY	$6.0 - $9.92 $45,318 - $74,925	7,553 Added 466.52%	9,172 $59,000
Q3 2021 Nov 12, 2021	BUY	$6.98 - $12.03 $11,300 - $19,476	1,619 New	1,619 $11,000

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $371M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.